Clinical Trials Browser

Phase 1 × INDUSTRY × lorvotuzumab mertansine × Clear all

NCT00346385 2015-03-26

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

DermatologicGynecologicThoracic

Ovarian Neoplasms, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT00991562 2014-11-21

IMGN901 in Combination With Lenalidomide and Dexamethasone

Phase 1 Completed

Multiple Myeloma, Recurrence

NCT00346255 2013-04-23

IMGN901

Phase 1 Completed

Multiple Myeloma